Shots
Cross-industry lessons from technology, design thinking, and startups can reshape drug development by encouraging faster iteration, disciplined decision-making, and a stronger focus on real patient needs, unlocking innovations that traditional biotech models may overlook.
Clinical experience and thoughtful engagement with the U.S. Food and Drug Administration highlight the importance of patient insights, transparent…
Shots:
Abbott’s AVEIR DR is the first in the world dual-chamber leadless pacemaker
Jerry Kelleher, a clinical trial participant in the AVEIR DR study, shares his transformative journey with PharmaShots
Explore Jerry’s miraculous recovery with AVEIR DR, which helped enhance his quality of life
Saurabh: Jerry, can you take us back to life and describe…

